| Drug Name: | Tolterodine (124937-51-5) |
|---|---|
| PubChem ID: | 443879 |
| SMILES: | CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2 |
| InchiKey: | OOGJQPCLVADCPB-HXUWFJFHSA-N |
| Therapeutic Category: | Cholinergic Agents, Cholinergic Antagonists, Muscarinic Antagonists, Neurotransmitter Agents, Urological Agents |
| Molecular Weight (dalton) | : | 325.496 |
| LogP | : | 5.34142 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 23.47 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Constipation | Cysteinyl leukotriene receptor 2 (Q9NS75) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Somnolence | Voltage-dependent P/Q-type calcium channel subunit alpha-1A (O00555) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category